Overview of new vaccines and technologies

Veterinary Microbiology

Volumn 117, Issue 1, 2006, Pages 25-31

  Chalmers, W S K ^a  

^a Intervet UK   (United Kingdom)

Author keywords

Emerging diseases; Technology; Vaccines

Indexed keywords

BACTERIAL VACCINE; DNA VACCINE; PROTOZOAL VACCINE; RECOMBINANT VACCINE; VIRUS VACCINE;

ADENOVIRUS; ANTIBODY RESPONSE; ARTICLE; AVIAN INFLUENZA; BABESIA; BABESIOSIS; CALICIVIRUS; CANINE DISTEMPER MORBILLIVIRUS; CAT DISEASE; CELLULAR IMMUNITY; DOG DISEASE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; FELINE PANLEUKOPENIA VIRUS; HERPES VIRUS; HOST; HUMORAL IMMUNITY; IMMUNE SYSTEM; INFECTION; LEISHMANIA INFANTUM; LEISHMANIASIS; LEPTOSPIRA; MOLECULAR BIOLOGY; MUCOSAL IMMUNITY; NONHUMAN; PARASITOSIS; PARVOVIRUS; VACCINATION; VACCINE PRODUCTION; VETERINARY MEDICINE; VIRUS CARRIER; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; CATS; DOGS; DRUG ADMINISTRATION ROUTES; GENETIC ENGINEERING; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; VACCINES;

EID: 33748479436     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.04.006     Document Type: Article

References (30)

1. Animal Pharm, 2005. DNA vaccines-simultaneous 'first ever' approvals, vol. 569, p. 1.
2. Bergman P.J., McKnight J., Novosad A., Charney S., Farrelly J., Craft D., Wulderk M., Jeffers Y., Sadelain M., Hohenhaus A.E., Segal N., Gregor P., Engelhorn M., Riviere I., Houghton A.N., and Wolchok J.D. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin. Cancer Res. 4 (2003) 1284-1290
3. Binns S.H., Dawson S., Speakman A.J., Cuevas L.E., Gaskell C.J., Hart C.A., Morgan K.L., and Gaskell R.M. Prevalence and risk factors for feline bordetella bronchiseptica infection. Vet. Rec. 144 (1999) 575-580
4. Buckley A., Dawson A., Moss S.R., Hinsley S.A., Bellamy P.E., and Gould E.A. Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J. Gen. Virol. 84 (2003) 2807-2817
5. Carey, S., 2004. Equine Influenza Virus-DVM Newsmagazine, 1 June, Internet.
6. Chalmers W.S., and Baxendale W. A comparison of canine distemper vaccine and measles vaccine for the prevention of canine distemper in young puppies. Vet. Rec. 135 (1994) 349-353
7. Churchill A.E. Preliminary development of a live attenuated canine parvovirus vaccine from an isolate of British origin. Vet. Rec. 120 (1987) 334-339
8. Drexler I., Staib C., and Sutter G. Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?. Curr. Opin. Biotechnol. 15 (2004) 506-512
9. Gaskell R.M., Gettinby G., Graham S.J., and Skilton D. Related articles, links veterinary products committee working group report on feline and canine vaccination. Vet. Rec. 150 (2002) 126-134
10. Greenwood N.M., Chalmers W.S., Baxendale W., and Thompson H. Comparison of isolates of canine parvovirus by restriction enzyme analysis, and vaccine efficacy against field strains. Vet. Rec. 136 (1995) 63-67
11. Jaganathan K.S., Rao Y.U., Singh P., Prabakaran D., Gupta S., Jain A., and Vyas S.P. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres. Int. J. Pharm. 294 (2005) 23-32
12. Jarrett O., and Ganiere J.P. Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine. Vet. Rec. 138 (1996) 7-11
13. Karaca K., Bowen R., Austgen L.E., Teehee M., Siger L., Grosenbaugh D., Loosemore L., Audonnet J.C., Nordgren R., and Minke J.M. Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge. Vaccine 23 (2005) 3808-3813
14. Kuiken T., Rimmelzwaan G., van Riel D., van Amerongen G., Baars M., Fouchier R., and Osterhaus A. Avian H5N1 influenza in cats. Science 306 (2004) 241
15. Kusuhara H., Hohdatsu T., Okumura M., Sato K., Suzuki Y., Motokawa K., Gemma T., Watanabe R., Huang C., Arai S., and Koyama H. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats. Vet. Microbiol. 108 (2005) 155-165
16. Le Fanu W.R. A Bio-Bibliography of Edward Jenner 1749-1823 (1951), Harvey and Blythe, London
17. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 (2005) 2825-2840
18. Levine A.S. Viruses 55: Scientific American Library (1992), W.H. Freeman & Company, New York
19. McCabe V.J., Tarpey I., and Spibey N. Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein. Vaccine 20 (2002) 2454-2462
20. Murgue B., Murris S., Zientara S., Durand B., Durand J.P., and Zeller H. West Nile outbreak in horses in Southern France, 2000: the return after 35 years. Emerg. Infect. Dis. 4 (2001) 692-696
21. Naz R.K. Contraceptive Vaccines Drugs 65 (2005) 593-603
22. Oyaski M.L., and Hildegunds C.I.E. DNA Vaccines Sci. Med. 7 (2000) 30-43
23. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11349-11353
24. Pasick J. Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Anim. Health Res. Rev. 2 (2004) 257-262
25. Pastoret P.P., and Brochier B. Epidemiology and control of fox rabies in Europe. Vaccine 17 (1999) 1750-1754
26. Schetters T. Related vaccination against canine babesiosis. Trends Parasitol. 21 4 (2005 Apr) 179-184 Review
27. Sparks A.H. Feline leukaemia virus: a review of immunity and vaccination. J. Small Anim. Pract. 38 (1997) 187-194
28. Thomas W.R., Hales B.J., and Smith W.A. Genetically engineered vaccines. Curr Allergy Asthma Rep. 3 (2005) 197-203
29. Tu C., Crameri G., Kong X., Chen J., Sun Y., Yu M., Xiang H., Xia X., Liu S., Ren T., Yu Y., Eaton B.T., Xuan H., and Wang L.F. Antibodies to SARS coronavirus in civets. Emerg. Infect. Dis. 12 (2004) 2244-2248
30. Wolf, A., 2001. Proceedings of the WSAVA World Congress on Vaccines of the Present and Future.